Literature DB >> 23946222

The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Michael Y Lin1, Rosie D Lyles-Banks, Karen Lolans, David W Hines, Joel B Spear, Russell Petrak, William E Trick, Robert A Weinstein, Mary K Hayden.   

Abstract

BACKGROUND: In the United States, Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae are increasingly detected in clinical infections; however, the colonization burden of these organisms among short-stay and long-term acute care hospitals is unknown.
METHODS: Short-stay acute care hospitals with adult intensive care units (ICUs) in the city of Chicago were recruited for 2 cross-sectional single-day point prevalence surveys (survey 1, July 2010-January 2011; survey 2, January-July 2011). In addition, all long-term acute care hospitals (LTACHs) in the Chicago region (Cook County) were recruited for a single-day point prevalence survey during January-May 2011. Swab specimens were collected from rectal, inguinal, or urine sites and tested for Enterobacteriaceae carrying blaKPC.
RESULTS: We surveyed 24 of 25 eligible short-stay acute care hospitals and 7 of 7 eligible LTACHs. Among LTACHs, 30.4% (119 of 391) of patients were colonized with KPC-producing Enterobacteriaceae, compared to 3.3% (30 of 910) of short-stay hospital ICU patients (prevalence ratio, 9.2; 95% confidence interval, 6.3-13.5). All surveyed LTACHs had patients harboring KPC (prevalence range, 10%-54%), versus 15 of 24 short-stay hospitals (prevalence range, 0%-29%). Several patient-level covariates present at the time of survey-LTACH facility type, mechanical ventilation, and length of stay-were independent risk factors for KPC-producing Enterobacteriaceae colonization.
CONCLUSIONS: We identified high colonization prevalence of KPC-producing Enterobacteriaceae among patients in LTACHs. Patients with chronic medical care needs in long-term care facilities may play an important role in the spread of these extremely drug-resistant pathogens.

Entities:  

Keywords:  Klebsiella pneumoniae carbapenemase; carbapenem-resistant Enterobacteriaceae; healthcare epidemiology; intensive care units; long-term care facilities

Mesh:

Substances:

Year:  2013        PMID: 23946222     DOI: 10.1093/cid/cit500

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  76 in total

Review 1.  Bloodstream infections in older patients.

Authors:  Dafna Yahav; Noa Eliakim-Raz; Leonard Leibovici; Mical Paul
Journal:  Virulence       Date:  2015-12-18       Impact factor: 5.882

Review 2.  Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.

Authors:  Ritu Banerjee; Romney Humphries
Journal:  Virulence       Date:  2016-05-11       Impact factor: 5.882

3.  Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam.

Authors:  Krystyna M Kazmierczak; Douglas J Biedenbach; Meredith Hackel; Sharon Rabine; Boudewijn L M de Jonge; Samuel K Bouchillon; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

4.  Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States.

Authors:  Joshua T Thaden; Sarah S Lewis; Kevin C Hazen; Kirk Huslage; Vance G Fowler; Rebekah W Moehring; Luke F Chen; Constance D Jones; Zack S Moore; Daniel J Sexton; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2014-06-20       Impact factor: 3.254

5.  Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, but Closer Attention from Regulatory Bodies Is Needed.

Authors:  James A McKinnell; S Bhaurla; P Marquez-Sung; A Pucci; M Baron; T Kamali; J Bugante; B Schwartz; S Balter; D Terashita; S Butler-Wu; J Gunzenhauser; J Hindler; R M Humphries
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

6.  Performance of different culture methods and of a commercial molecular assay for the detection of carbapenemase-producing Enterobacteriaceae in nursing homes and rehabilitation centers.

Authors:  V Saegeman; J Van den Eynde; L Niclaes; D De Ridder; A Schuermans; Y Glupczynski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-21       Impact factor: 3.267

7.  Pathogen population structure can explain hospital outbreaks.

Authors:  Fabrizio Spagnolo; Pierre Cristofari; Nicholas P Tatonetti; Lev R Ginzburg; Daniel E Dykhuizen
Journal:  ISME J       Date:  2018-07-25       Impact factor: 10.302

8.  Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.

Authors:  Jonathan A Otter; Eleonora Dyakova; Karen N Bisnauthsing; Antonio Querol-Rubiera; Amita Patel; Chioma Ahanonu; Olga Tosas Auguet; Jonathan D Edgeworth; Simon D Goldenberg
Journal:  J Antimicrob Chemother       Date:  2016-08-11       Impact factor: 5.790

9.  A model for predicting nosocomial carbapenem-resistant Klebsiella pneumoniae infection.

Authors:  Duo Yang; Zeqiang Xie; Xuli Xin; Wenying Xue; Man Zhang
Journal:  Biomed Rep       Date:  2016-09-07

10.  Community Origins and Regional Differences Highlight Risk of Plasmid-mediated Fluoroquinolone Resistant Enterobacteriaceae Infections in Children.

Authors:  Latania K Logan; Rachel L Medernach; Jared R Rispens; Steven H Marshall; Andrea M Hujer; T Nicholas Domitrovic; Susan D Rudin; Xiaotian Zheng; Nadia K Qureshi; Sreenivas Konda; Mary K Hayden; Robert A Weinstein; Robert A Bonomo
Journal:  Pediatr Infect Dis J       Date:  2019-06       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.